Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Resistance”

997 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 997 results

Not applicableStudy completedNCT05177952
What this trial is testing

Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis

Who this might be right for
Training StudyMultiple SclerosisBlood Flow Restriction
University of Central Florida 20
Testing effectiveness (Phase 2)UnknownNCT02893306
What this trial is testing

MSC Administration for the Management of Type 1 Diabetic Patients

Who this might be right for
Type 1 Diabetes Mellitus
Universidad del Desarrollo 10
Not applicableStudy completedNCT03048708
What this trial is testing

Thyroid in Bariatric Surgery

Who this might be right for
ThyroidObesityInsulin Resistance+1 more
University Hospitals Coventry and Warwickshire NHS Trust 10
Testing effectiveness (Phase 2)Study completedNCT05311514
What this trial is testing

Allogeneic Platelet Lysate Eye Drops for the Treatment of Severe Chronic Ocular Graft-versus-host Disease

Who this might be right for
Ocular Graft-versus-host Disease
St. Petersburg State Pavlov Medical University 38
Not applicableUnknownNCT04208074
What this trial is testing

Exercise Study for Breast Cancer Survivors

Who this might be right for
Breast Cancer
San Diego Biomedical Research Institute 30
Not applicableActive Not RecruitingNCT05388474
What this trial is testing

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Who this might be right for
HIV InfectionsMulti-Antiviral Resistance
Theratechnologies 168
Testing effectiveness (Phase 2)Study completedNCT00109590
What this trial is testing

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 175
Not applicableLooking for participantsNCT06315725
What this trial is testing

Effect of Artificial Sweetener (AFS) on Glucose Metabolism in Patients with Type 1 Diabetes (T1D)

Who this might be right for
Type 1 Diabetes (T1D)Healthy Subjects
McGill University Health Centre/Research Institute of the McGill University Health Centre 25
Testing effectiveness (Phase 2)Ended earlyNCT00490776
What this trial is testing

Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Cutaneous T-Cell Lymphoma
Novartis Pharmaceuticals 9
Early research (Phase 1)UnknownNCT02186860
What this trial is testing

Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Affiliated Hospital to Academy of Military Medical Sciences 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT06056791
What this trial is testing

Study of INKmune in Patients With mCRPC (CaRe Prostate)

Who this might be right for
CancerMetastatic Castration-resistant Prostate CancermCRPC
Inmune Bio, Inc. 30
Large-scale testing (Phase 3)Active Not RecruitingNCT02362503
What this trial is testing

Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients

Who this might be right for
HIV Infections
ViiV Healthcare 371
Testing effectiveness (Phase 2)Study completedNCT03365791
What this trial is testing

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

Who this might be right for
Small Cell Lung CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+5 more
Novartis Pharmaceuticals 76
Not applicableStudy completedNCT00351442
What this trial is testing

Examining Factors That May Influence Resistance to HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 522
Not applicableStudy completedNCT00262717
What this trial is testing

Can Resistance Enhance Selection of Treatment? (CREST)

Who this might be right for
HIV Infection
Kirby Institute 338
Not applicableUnknownNCT01330342
What this trial is testing

Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma

Who this might be right for
HIVLymphoma
St Stephens Aids Trust 40
Post-approval studies (Phase 4)WithdrawnNCT00456313
What this trial is testing

No Resistance After Long Term Treatment SERETIDE

Who this might be right for
Asthma
GlaxoSmithKline
Not applicableStudy completedNCT01518660
What this trial is testing

Multiple Sclerosis and Progressive Resistance Training

Who this might be right for
Multiple Sclerosis (Relapsing Remitting)
University of Aarhus 35
Early research (Phase 1)Study completedNCT00589381
What this trial is testing

Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 30
Not applicableLooking for participantsNCT06022549
What this trial is testing

Effects of mHealth Message on Metabolic Syndrome and Bone Loss of HIV Infected Persons in Taiwan

Who this might be right for
Hiv
National Taiwan University 400
Load More Results